Insulet Corporation (PODD) is a publicly traded Healthcare sector company. As of August 24, 2026, PODD trades at $149.35 with a market cap of $10.28B and a P/E ratio of 27.73. PODD moved +0.00% today. Year to date, PODD is -47.88%; over the trailing twelve months it is -54.81%. Its 52-week range spans $126.40 to $354.88. Analyst consensus is buy with an average price target of $174.45. Rallies surfaces PODD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest PODD news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $149.35 |
| Market Cap | $10.28B |
| P/E Ratio | 27.73 |
| EPS | $5.35 |
| Dividend Yield | 0.00% |
| 52-Week High | $354.88 |
| 52-Week Low | $126.40 |
| Volume | 62.56K |
| Avg Volume | 0 |
| Revenue (TTM) | $3.05B |
| Net Income | $375.30M |
| Gross Margin | 71.08% |
23 analysts cover PODD: 0 strong buy, 13 buy, 9 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $174.45.